Primary |
Type 1 Diabetes Mellitus |
37.9% |
Type 2 Diabetes Mellitus |
19.0% |
Product Used For Unknown Indication |
17.2% |
Diabetes Mellitus |
12.1% |
Hyperglycaemia |
10.3% |
Diabetes |
1.7% |
Hyperkalaemia |
1.7% |
|
Blood Glucose Decreased |
11.8% |
Blood Glucose Increased |
11.8% |
Hypoglycaemia |
11.8% |
Lethargy |
11.8% |
Somnolence |
5.9% |
Tremor |
5.9% |
Depressed Level Of Consciousness |
2.9% |
Diabetic Ketoacidosis |
2.9% |
Dizziness |
2.9% |
Erectile Dysfunction |
2.9% |
Feeling Cold |
2.9% |
Hyperhidrosis |
2.9% |
Hypoglycaemic Seizure |
2.9% |
Incoherent |
2.9% |
Loss Of Consciousness |
2.9% |
Medication Error |
2.9% |
Mental Status Changes |
2.9% |
Nausea |
2.9% |
Paraesthesia Oral |
2.9% |
Tachycardia |
2.9% |
|
Secondary |
Type 2 Diabetes Mellitus |
38.8% |
Type 1 Diabetes Mellitus |
11.5% |
Drug Use For Unknown Indication |
10.5% |
Diabetes Mellitus |
9.7% |
Product Used For Unknown Indication |
3.8% |
Hypertension |
3.3% |
General Anaesthesia |
2.5% |
Anaesthesia |
2.2% |
Antiretroviral Therapy |
2.2% |
Hyperemesis Gravidarum |
1.9% |
Schizophrenia |
1.9% |
Constipation |
1.7% |
Hyperglycaemia |
1.6% |
Hypokalaemia |
1.6% |
Hypotonia |
1.6% |
Sedation |
1.3% |
Depression |
1.1% |
Rhinitis Allergic |
0.9% |
Sinusitis |
0.9% |
Type I Diabetes Mellitus |
0.9% |
|
Hypotension |
17.1% |
Renal Failure Acute |
12.6% |
Pulmonary Oedema |
9.0% |
Vomiting |
8.1% |
Loss Of Consciousness |
7.2% |
Nausea |
7.2% |
Pancreatitis |
4.5% |
Herpes Zoster Infection Neurological |
3.6% |
Hypoglycaemia |
3.6% |
Insulin C-peptide Decreased |
3.6% |
Hyperglycaemia |
2.7% |
Mental Status Changes |
2.7% |
Syncope |
2.7% |
Systemic Inflammatory Response Syndrome |
2.7% |
Vaginal Discharge |
2.7% |
Weight Increased |
2.7% |
Blood Glucose Increased |
1.8% |
Cutaneous Amyloidosis |
1.8% |
Dehydration |
1.8% |
Hyperhidrosis |
1.8% |
|
Concomitant |
Drug Use For Unknown Indication |
28.0% |
Product Used For Unknown Indication |
28.0% |
Diabetes Mellitus |
12.1% |
Type 2 Diabetes Mellitus |
5.6% |
Hypertension |
4.6% |
Pain |
2.8% |
Rheumatoid Arthritis |
2.4% |
Prophylaxis |
1.9% |
Type 1 Diabetes Mellitus |
1.5% |
Depression |
1.5% |
T-cell Type Acute Leukaemia |
1.4% |
Medical Diet |
1.4% |
Coronary Artery Disease |
1.4% |
Adverse Event |
1.2% |
Constipation |
1.1% |
Hypercholesterolaemia |
1.1% |
Thrombosis Prophylaxis |
1.1% |
Asthma |
1.0% |
Gastrooesophageal Reflux Disease |
0.9% |
Aplastic Anaemia |
0.9% |
|
Vomiting |
12.5% |
Pyrexia |
11.1% |
Hypoglycaemia |
7.2% |
Respiratory Failure |
6.8% |
Nausea |
5.4% |
Renal Failure |
5.4% |
Atrial Fibrillation |
5.0% |
Renal Failure Acute |
5.0% |
Renal Impairment |
4.3% |
Loss Of Consciousness |
3.9% |
Weight Decreased |
3.9% |
Rhabdomyolysis |
3.6% |
Death |
3.2% |
Eosinophilic Myocarditis |
3.2% |
Hepatic Function Abnormal |
3.2% |
Pneumonia |
3.2% |
Somnolence |
3.2% |
Staphylococcal Infection |
3.2% |
Syncope |
3.2% |
Wheezing |
3.2% |
|
Interacting |
Drug Use For Unknown Indication |
73.3% |
Diabetes Mellitus Insulin-dependent |
8.3% |
Diabetes Mellitus |
3.3% |
Hypertension |
3.3% |
Neuralgia |
3.3% |
Rheumatoid Arthritis |
3.3% |
Back Pain |
1.7% |
Pain |
1.7% |
Restlessness |
1.7% |
|
Hypoglycaemia |
71.4% |
Drug Interaction |
14.3% |
Urinary Incontinence |
14.3% |
|